Whats New

Anticoagulation Achievement Awards

Is the anticoagulation care you receive from you GP, pharmacist, nurse or VTE team, brilliant? The prestigious Anticoagulation Achievement Awards are seeking applications from outstanding clinical teams and individuals who provide exemplary care for any patient who has been diagnosed with atrial fibrillation or a blood clot such as a DVT (deep vein thrombosis) or a PE (pulmonary embolism). If you know a clinician who makes all the difference to your care for any of these conditions, please share this information with them. If you are a clinician reading this please find out more about the awards to see if you could apply. Not only could you receive national recognition for your services and care, but also win a £1000 bursary. Further information and application form available on: www.anticoagulationawards.org

Read more »

Questionnaire for people who self-test their INR

Do you use a home test for the monitoring of a medical condition? This could include measuring your blood glucose or your blood coagulation (INR). If so, we could like to invite you to participate in a questionnaire study. Your responses will be anonymous and the questionnaire can be completed online or in paper format and will take approximately 15-20 minutes. This study is being done by the NIHR Diagnostic Evidence Co-operative London that is based at Imperial College London. The purpose of this research study is to user-test a questionnaire that we have designed with patients to measure how home test devices impact on the lives of their users. We believe that measuring this information will provide an important perspective when decisions are being made about whether or not to introduce a new test. For more information please click on the following link: https://imperial.eu.qualtrics.com/SE/?SID=SV_6W3lkthTUL2Ahr7 Alternatively, if you would like more details in paper format or have any other questions please contact Jeremy Huddy (Email j.huddy@imperial.ac.uk Telephone: 0203 3126532).

Read more »

Preventing deep vein thrombosis by improving blood flow in the calf veins of the leg

Deep vein thrombosis is a serious condition that occurs when blood clots form inside a vein located deep in your leg. One possible way to help reduce the risk of blood clots is to increase the amount of blood flow through the calf veins. One device that can do that is the Geko device.
Download the article

Read more »

Thrombosis Voices in Partnership Programme (ViPs) for patients

AntiCoagulation Europe (ACE) are working in partnership with LEO Pharma and their research partners to find people who have cancer and have experienced thrombosis (usually referred to as a blood clot, Deep Vein Thrombosis (DVT) or a Pulmonary Embolism (PE) to join their ViP programme. The ViP programme is designed to bring patients with similar experiences together, so that they can share their stories and help to build activities and ideas which will improve the patient experience for many others. Please click on the title above to find out more.

Read more »

NICE publishes options for local implementation of Novel Oral Anticoagulants

NICE has issued technology appraisal guidance on the use of the 4 non-vitamin K antagonist oral anticoagulants (NOACs), apixaban, dabigatran, edoxaban and rivaroxaban, in several clinical settings. All 4 NOACs must be included in local formularies for use in line with this guidance, with no additional funding or formulary restrictions. nice.org.uk/guidance/ktt16

Read more »

Buy copies of our magazine AnticoagulationUK online

You can now buy individual copies of our magazine AnticoagulationUK online for £3.00. Just click on the flashing image above. If you want to support us on a long term basis you can still sign up to be a member on the join us page and receive 4 copies for £10.00. We hope you enjoy reading AnticoagulationUK

Read more »

NICE recommends Edoxaban for two indications

The National Institute for Health and Care Excellence (NICE) has recommended Edoxaban (Lixiana) as an option for the treatment and secondary prevention of deep vein thrombosis and pulmonary embolism and for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Read more »

NICE publishes Quality Standard for Atrial Fibrillation

This quality standard covers identification, treatment and management of atrial fibrillation (including paroxysmal, persistent and permanent atrial fibrillation, and atrial flutter) in adults (18 years and older). It includes a Quality Statement on Self-managment with coagulometers for people with AF and also a Quality Statement on not using aspirin as a sole therapy for stroke prevention in AF.

Read more »

Ready for Change? An Audit of Local Commissioning

ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.

Read more »

NICE issues guidance for self-monitoring for people with AF or replacement heart valves

24th Sept 2014 The National Institute of Health and Care Excellence (NICE) has recommended self-monitoring of INR levels for people with atrial fibrillation and people with replacement heart valves - if the person prefers this form of testing and if the person or their carer is both physically and cognitively able to self-monitor effectively.

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space